{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:44:14Z","timestamp":1791513854143,"version":"4.3.4"},"reference-count":81,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.trre.2011.10.002","type":"journal-article","created":{"date-parts":[[2011,12,4]],"date-time":"2011-12-04T06:50:19Z","timestamp":1322981419000},"page":"3-13","source":"Crossref","is-referenced-by-count":209,"title":["Proteinuria: detection and role in native renal disease progression"],"prefix":"10.1016","volume":"26","author":[{"given":"Jose Luis","family":"Gorriz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Martinez-Castelao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2011.10.002_bb0005","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2011.10.002_bb0010","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1046\/j.1523-1755.1998.00874.x","article-title":"Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. \u201cGruppo Italiano di Studi Epidemiologici in Nefrologia\u201d (GISEN)","volume":"53","author":"Ruggenenti","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2011.10.002_bb0015","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0272-6386(99)70442-7","article-title":"Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation","volume":"33","author":"Keane","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2011.10.002_bb0020","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1681\/ASN.2007101065","article-title":"Extended prognostic value of urinary albumin excretion for cardiovascular events","volume":"19","author":"Brantsma","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2011.10.002_bb0025","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1681\/ASN.2005121352","article-title":"Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening","volume":"17","author":"Halbesma","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2011.10.002_bb0030","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1093\/ndt\/gfn356","article-title":"Cardiovascular and renal outcome in subjects with K\/DOQI stage 1\u20133 chronic kidney disease: the importance of urinary albumin excretion","volume":"23","author":"Brantsma","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2011.10.002_bb0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/ndt\/gfg533","article-title":"Proteinuria and interstitial injury","volume":"19","author":"Eddy","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2011.10.002_bb0040","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s001250050140","article-title":"Reduction of albuminuria predicts beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment","volume":"37","author":"Rossing","year":"1994","journal-title":"Diabeteologia"},{"issue":"Suppl 45","key":"10.1016\/j.trre.2011.10.002_bb0045","first-page":"S174","article-title":"Short term antiproteinuric response to antihypertensive treatment predicts long-term GFR decline in patients with non-diabetic renal disease","author":"Apperloo","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2011.10.002_bb0050","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2011.10.002_bb0055","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2011.10.002_bb0060","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1681\/ASN.2009070737","article-title":"Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy","volume":"20","author":"Mehdi","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2011.10.002_bb0065","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa0708379","article-title":"Aliskiren combined with losartan in type 2 diabetes and nephropathy","volume":"358","author":"Parving","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2011.10.002_bb0070","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1681\/ASN.2006050445","article-title":"Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) trial","volume":"18","author":"Eijkelkamp","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2011.10.002_bb0075","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1046\/j.1523-1755.2001.0600031131.x","article-title":"Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease","volume":"60","author":"Jafar","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2011.10.002_bb0080","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(98)10363-X","article-title":"Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria","volume":"354","author":"Ruggenenti","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.trre.2011.10.002_bb0085","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2011.10.002_bb0090","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1111\/j.1523-1755.2004.00653.x","article-title":"1. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL","volume":"65","author":"De Zeew","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2011.10.002_bb0095","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1681\/ASN.2009060593","article-title":"Avosentan for overt diabetic nephropathy","volume":"21","author":"Mann","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2011.10.002_bb0100","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1053\/j.ajkd.2008.01.025","article-title":"The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis","volume":"52","author":"McCormick","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2011.10.002_bb0105","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(10)61032-X","article-title":"Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial","volume":"376","author":"De Zeew","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.trre.2011.10.002_bb0110","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/ki.1979.130","article-title":"Pathophysiology of Tamm-Horsfall protein","volume":"16","author":"Hoyer","year":"1979","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2011.10.002_bb0115","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00004872-200203000-00002","article-title":"Microalbuminuria in essential hypertension: redefining the threshold","volume":"20","author":"Redon","year":"2002","journal-title":"J Hypertens"},{"key":"10.1016\/j.trre.2011.10.002_bb0120","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"2007 Guidelines for the management of arterial hypertension. The task force for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology","volume":"25","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.trre.2011.10.002_bb0125","unstructured":"NICE Guidelines. National Institute for Health and Clinical Excellence.Chronic Kidney Disease: National Clinical Guideline for Early Identification and Management in Adults in Primary and Secundary Care. Clinical Guideline 73 , 2008. http:\/\/www.nice.org.uk\/Guidance\/cg73."},{"key":"10.1016\/j.trre.2011.10.002_bb0130","unstructured":"Joint Specialty Committee on Renal Medicine of the Royal College of Physicians and the Renal Association, and the Royal College of General Practitioners. Chronic Kidney Disease in Adults: UK Guidelines for Identification, Management and Referral. London: Royal College of Physicians [Internet], 2006; http:\/\/www.renal.org\/CKDguide\/full\/CKDprintedfullguide.pdf."},{"key":"10.1016\/j.trre.2011.10.002_bb0135","unstructured":"CARI guidelines. Caring for Australasians with Renal Impairment (CARI). Chronic Kidney Disease Guidelines: Urine Protein as Diagnostic Test [Internet], 2004; [consultado el 15-6-2010]. Accesible at http:\/\/www.cari.org.au\/ckd_urineprot_list_pub2004.php."},{"key":"10.1016\/j.trre.2011.10.002_bb0140","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJM198407123110204","article-title":"Predicting diabetic nephropathy in insulin-dependent patients","volume":"311","author":"Mogensen","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2011.10.002_bb0145","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(83)92462-5","article-title":"Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy","volume":"1","author":"Parving","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.trre.2011.10.002_bb0150","first-page":"277","article-title":"Microalbuminuria and urinary albumin excretion: French guidelines","volume":"66","author":"Halimi","year":"2008","journal-title":"Ann Biol Clin (Paris)"},{"key":"10.1016\/j.trre.2011.10.002_bb0155","first-page":"1","article-title":"Documento de Consenso. Recomendaciones sobre la valoraci\u00f3n de la proteinuria en el diagn\u00f3stico y seguimiento de la enfermedad renal cr\u00f3nica","volume":"31","author":"Monta\u00f1\u00e9s Bermudez","year":"2011","journal-title":"Nefrologia"},{"key":"10.1016\/j.trre.2011.10.002_bb0160","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1373\/clinchem.2008.106567","article-title":"Current issues in measurement and reporting of urinary albumin excretion","volume":"55","author":"Miller","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.trre.2011.10.002_bb0165","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/sj.ki.5001729","article-title":"Time to abandon microalbuminuria?","volume":"70","author":"Ruggenenti","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2011.10.002_bb0170","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1093\/ndt\/gfg314","article-title":"Association between albuminuria and proteinuria in the general population: the AusDiab Study","volume":"18","author":"Atkins","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2011.10.002_bb0175","first-page":"104","article-title":"Use of urine albumin measurement as a replacement for total protein","volume":"43","author":"Newman","year":"1995","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.trre.2011.10.002_bb0180","doi-asserted-by":"crossref","first-page":"535-4","DOI":"10.3949\/ccjm.70.6.535","article-title":"Proteinuria: how to evaluate an important finding","volume":"70","author":"Kashif","year":"2003","journal-title":"Cleve Clin J Med"},{"issue":"Suppl 1","key":"10.1016\/j.trre.2011.10.002_bb0185","first-page":"S11","article-title":"Standards of medical care in diabetes. Clinical practice recommendations. American Diabetes Association","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.trre.2011.10.002_bb0190","series-title":"Tietz Textbook of Clinical Chemistry and Molecular Diagnostics","article-title":"Kidney function test","author":"Lamb","year":"2006"},{"key":"10.1016\/j.trre.2011.10.002_bb0195","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1258\/0004563001899041","article-title":"Urine dipstick testing: comparison of results obtained by visual reading and with the Bayer CLINITEK 50","volume":"37","author":"Rumley","year":"2000","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.trre.2011.10.002_bb0200","unstructured":"Scottish Intercollegiate Guidelines Network. Diagnosis and management of chronic kidney disease: Guideline 103 [Internet], 2008. http:\/\/www.sign.ac.uk\/guidelines\/fulltext\/103\/index.html."},{"key":"10.1016\/j.trre.2011.10.002_bb0205","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/ndt\/gfn612","article-title":"Use of a first-line urine protein-to-creatinine ratio strip test on random urines to rule out proteinuria in patients with chronic kidney disease","volume":"24","author":"Guy","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2011.10.002_bb0210","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cca.2008.09.006","article-title":"Diagnostic accuracy of the urinary albumin: creatinine ratio determined by the CLINITEK Microalbumin and DCA 2000+ for the rule-out of albuminuria in chronic kidney disease","volume":"399","author":"Guy","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.trre.2011.10.002_bb0215","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/clinchem\/31.8.1377","article-title":"Three turbidimetric methods for determining total protein compared","volume":"31","author":"Nishi","year":"1985","journal-title":"Clin Chem"},{"key":"10.1016\/j.trre.2011.10.002_bb0220","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1373\/clinchem.2007.100917","article-title":"Postanalytical external quality assessment of urine albumin in primary health care: an international survey","volume":"54","author":"Aakre","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.trre.2011.10.002_bb0225","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1373\/clinchem.2004.039743","article-title":"Characterization of immunochemically nonreactive urinary albumin","volume":"50","author":"Osicka","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.trre.2011.10.002_bb0230","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1373\/clinchem.2006.078832","article-title":"A liquid chromatography-mass spectrometry method for the quantification of urinary albumin using a novel 15N-isotopically labeled albumin internal standard","volume":"53","author":"Singh","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.trre.2011.10.002_bb0235","unstructured":"Sociedad Espa\u00f1ola de Bioqu\u00edmica Cl\u00ednica y Patolog\u00eda Molecular. XVIII Programa de Garant\u00eda Externa de la Calidad de Bioqu\u00edmica (orina) [Internet], 2008; [consultado el 15-6-2010]. Accesible at: http:\/\/www.contcal.org\/k3\/docs\/2010\/ANUAL\/orina.pdf."},{"key":"10.1016\/j.trre.2011.10.002_bb0240","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1111\/j.1523-1755.2005.09408.x","article-title":"The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population","volume":"94","author":"Gansevoort","year":"2005","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.trre.2011.10.002_bb0245","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0140-6736(95)91747-0","article-title":"Prevention of diabetic renal disease with special reference to microalbuminuria","volume":"346","author":"Mogensen","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.trre.2011.10.002_bb0250","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1097\/01.ASN.0000100145.27188.33","article-title":"Management of glomerular proteinuria: a commentary","volume":"14","author":"Wilmer","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2011.10.002_bb0255","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1053\/j.ajkd.2007.06.013","article-title":"Testing for chronic kidney disease: a position statement from the National Kidney Foundation","volume":"50","author":"Vassalotti","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2011.10.002_bb0260","doi-asserted-by":"crossref","first-page":"892","DOI":"10.2215\/CJN.05280610","article-title":"The urine albumin-to-creatinine ratio: assessment of its performance in the renal transplant recipient population","volume":"6","author":"Erman","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2011.10.002_bb0265","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1365-2796.2003.01157.x","article-title":"Microalbuminuria and hypertension with focus on type 1 and 2 diabetes","volume":"254","author":"Mogensen","year":"2003","journal-title":"J Intern Med"},{"key":"10.1016\/j.trre.2011.10.002_bb0270","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1161\/01.HYP.0000154082.72286.2a","article-title":"Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: a LIFE study","volume":"45","author":"Ibsen","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.trre.2011.10.002_bb0275","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.286.4.421","article-title":"HOPE study investigators. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals","volume":"286","author":"Gerstein","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.trre.2011.10.002_bb0280","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0272-6386(00)70054-0","article-title":"Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury","volume":"35","author":"Ruggenenti","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2011.10.002_bb0285","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1136\/bmj.38814.566019.2F","article-title":"Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial","volume":"332","author":"Tonelli","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.trre.2011.10.002_bb0290","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2011.10.002_bb0295","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1053\/j.ajkd.2009.04.001","article-title":"Definition and classification of CKD: the debate should be about patient prognosis\u2014a position statement from KDOQI and KDIGO","volume":"53","author":"Eckardt","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2011.10.002_bb0300","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1681\/ASN.2008010110","article-title":"Staging of chronic kidney disease: time for a course correction","volume":"19","author":"Bauer","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2011.10.002_bb0305","doi-asserted-by":"crossref","first-page":"c39","DOI":"10.1159\/000151244","article-title":"The global burden of chronic kidney disease: how valid are the estimates?","volume":"110","author":"Glassock","year":"2008","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.trre.2011.10.002_bb0310","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/ndt\/gfn028","article-title":"Fact or fiction of the epidemic of chronic kidney disease\u2014let us not squabble about estimated GFR only, but also focus on albuminuria","volume":"23","author":"de Jong","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2011.10.002_bb0315","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/jama.2011.468","article-title":"Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality","volume":"305","author":"Peralta","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.trre.2011.10.002_bb0320","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.0000031732.78052.81","article-title":"Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population","volume":"106","author":"Hillege","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.trre.2011.10.002_bb0325","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1681\/ASN.2008121270","article-title":"Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes","volume":"20","author":"Ninomiya","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2011.10.002_bb0330","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.2010.650","article-title":"US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008","volume":"303","author":"Egan","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.trre.2011.10.002_bb0335","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/01.CIR.0000139860.33974.28","article-title":"Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy","volume":"110","author":"De Zeew","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.trre.2011.10.002_bb0340","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/pgmj.2004.021287","article-title":"Recent advances in diabetic nephropathy","volume":"80","author":"Marshall","year":"2004","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.trre.2011.10.002_bb0345","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1056\/NEJM199403313301301","article-title":"The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease","volume":"330","author":"Klahr","year":"1994","journal-title":"N Engl Med"},{"key":"10.1016\/j.trre.2011.10.002_bb0350","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1681\/ASN.2004090763","article-title":"Impact of achieved blood pressure on cardiovascular outcomes in the irbesartan diabetic nephropathy trial","volume":"16","author":"Berl","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2011.10.002_bb0355","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2011.10.002_bb0360","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/01.mnh.0000242172.06459.7c","article-title":"Obesity, proteinuria and progression of renal failure","volume":"15","author":"Praga","year":"2006","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.trre.2011.10.002_bb0365","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/01.HYP.26.4.670","article-title":"Effects of hypertension and dyslipidemia on the decline in renal function","volume":"26","author":"Manttari","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.trre.2011.10.002_bb0370","first-page":"180","article-title":"Cigarette smoking and kidney dysfunction in diabetes mellitus","volume":"21","author":"Cignarelli","year":"2008","journal-title":"J Nephrol"},{"key":"10.1016\/j.trre.2011.10.002_bb0375","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/ki.2008.128","article-title":"Proteinuria in diabetic kidney disease: a mechanistic viewpoint","volume":"74","author":"Jefferson","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2011.10.002_bb0380","doi-asserted-by":"crossref","first-page":"H1177","DOI":"10.1152\/ajpheart.2000.278.4.H1177","article-title":"Role of a glycocalyx on coronary arteriole permeability to proteins: evidence from enzyme treatments","volume":"278","author":"Huxley","year":"2000","journal-title":"Am J Physiol Herat Circ Physiol"},{"key":"10.1016\/j.trre.2011.10.002_bb0385","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1152\/physrev.00020.2002","article-title":"Cell biology of theglomerular podocyte","volume":"83","author":"Pavenstad","year":"2003","journal-title":"Physiol Rev"},{"key":"10.1016\/j.trre.2011.10.002_bb0390","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00467-004-1494-0","article-title":"Protein reabsorption in renal proximal tubule\u2014function and dysfunction in kidney pathophysiology","volume":"19","author":"Christensen","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.trre.2011.10.002_bb0395","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/sj.ki.5000141","article-title":"Renal albumin absorption in physiology and pathology","volume":"69","author":"Birn","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2011.10.002_bb0400","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1113\/jphysiol.2003.048074","article-title":"Transforming growth factor-beta1 reduces megalin- and cubilin-mediated endocytosis of albumin in proximal\u2013tubule-derived opossum kidney cells","volume":"552","author":"Gekle","year":"2003","journal-title":"J Physiol"},{"key":"10.1016\/j.trre.2011.10.002_bb0405","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1681\/ASN.2006040377","article-title":"How does proteinuria cause progressive renal damage?","volume":"17","author":"Abbate","year":"2006","journal-title":"J Am Soc Nephrol"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X11000875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X11000875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T11:00:03Z","timestamp":1639825203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X11000875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0955470X11000875"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2011.10.002","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}